• Call: 7506942069
  • Mumbai, India
  • Mon - Fri: 9.00am - 04.00pm

ESOPEC, CheckMate 577, and Neo-AEGIS: Breakthroughs in Esophageal Cancer Treatment

In this comprehensive video, Dr. Gunjan Desai, a Gastrointestinal, Liver, and Pancreatic Surgeon at Lilavati Hospital, Mumbai, takes viewers through an in-depth explanation of the ESOPEC trial and its impact on the treatment of esophageal adenocarcinoma.

Dr. Desai begins by providing a detailed overview of the ESOPEC trial, exploring its methodology, patient selection, and outcomes. He highlights the significance of this pivotal trial in advancing treatment protocols for esophageal cancer and shares insights into how its findings could change clinical practice.

The video then transitions to an analysis of other key trials in esophageal cancer treatment, including the CheckMate 577 trial, which investigates the use of adjuvant nivolumab for esophageal cancer, and the Neo-aegis trial, which examines neoadjuvant therapies. Dr. Desai discusses the implications of these studies for patient outcomes and current treatment paradigms.

Finally, Dr. Desai delves into the future of esophageal cancer treatment, exploring the evolving role of TNT (trimodality therapy) and the potential combination of FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) and CROSS regimens. He emphasizes the importance of personalized care and the need for ongoing clinical trials to refine these therapies for better survival rates and quality of life for patients.

This video is an essential resource for oncologists, surgeons, medical students, and anyone interested in the cutting-edge research and therapies available for esophageal cancer. Dr. Desai’s expert commentary provides clarity on complex trials and gives a glimpse into the promising future of esophageal cancer treatment.

Key Topics Covered:

  • ESOPEC trial and its impact on esophageal adenocarcinoma
  • CheckMate 577 trial results and its significance
  • Neo-aegis trial in the context of neoadjuvant treatment
  • The road ahead with TNT in esophageal cancer
  • The combination of FLOT and CROSS regimens for improved patient outcomes

Stay tuned to learn from one of the leading experts in the field of gastrointestinal surgery. Don't forget to like, subscribe, and hit the notification bell for more insightful medical discussions.




FACEBOOK: https://bit.ly/3qaO53R

TWITTER: https://bit.ly/3legZw7

INSTAGRAM: https://bit.ly/33mAJaK

E-MAIL ID: learnwithedusurg@gmail.com

WE SUPPORT AND RECOMMEND

Freedom of expression, positivity, and meditation

VISIT THE LINK, IF YOU DO TOO.

OUR MOST VIEWED SURGERY VIDEOS

STEP BY STEP LAPAROSCOPIC CHOLECYSTECTOMY

CRITICAL VIEW OF SAFETY IN LAP CHOLECYSTECTOMY